HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $310,000 | -92.6% | 18,355 | -91.5% | 0.08% | -85.5% |
| Q1 2018 | $4,210,000 | +266.1% | 214,887 | +278.5% | 0.59% | +324.6% |
| Q4 2017 | $1,150,000 | +55.6% | 56,773 | +33.4% | 0.14% | +70.4% |
| Q3 2017 | $739,000 | +84.3% | 42,573 | +36.1% | 0.08% | +65.3% |
| Q2 2017 | $401,000 | +2.8% | 31,273 | +4.0% | 0.05% | +2.1% |
| Q1 2017 | $390,000 | +124.1% | 30,073 | +71.1% | 0.05% | +54.8% |
| Q4 2016 | $174,000 | -17.9% | 17,573 | 0.0% | 0.03% | -38.0% |
| Q3 2016 | $212,000 | +29.3% | 17,573 | -7.4% | 0.05% | +22.0% |
| Q2 2016 | $164,000 | -65.0% | 18,973 | -61.7% | 0.04% | -73.0% |
| Q1 2016 | $469,000 | -23.5% | 49,573 | +40.0% | 0.15% | -58.8% |
| Q4 2015 | $613,000 | – | 35,400 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |